, Tracking Stock Market Picks
Enter Symbol:
Horizon Pharma Inc (HZNP) [hlAlert]

up 112.83 %

Horizon Pharma Inc (HZNP) rated Buy with price target $18 by Brean Capital

Posted on: Thursday,  Jan 8, 2015  8:25 AM ET by Brean Capital

Brean Capital rated Buy Horizon Pharma Inc (NASDAQ: HZNP) on 01/08/2015, when the stock price was $14.41. Since
then, Horizon Pharma Inc has gained 112.84% as of 01/19/2016's recent price of $30.67.
If you would have followed this Brean Capital's recommendation on HZNP, you would have gained 112.83% of your investment in 376 days.

Horizon Pharma, Inc. (Horizon) is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. On April 23, 2011, the United States Food and Drug Administration, approved DUEXIS (formerly HZT-501), a tablet formulation containing a fixed-dose combination of ibuprofen and famotidine in a single pill. The Company?s other product, LODOTRA (NP-01), is a programmed release formulation of low-dose prednisone that is marketed in Europe by the Company?s distribution partner, Mundipharma International Corporation Limited (Mundipharma). As of December 31, 2010, Horizon completed multiple Phase III clinical trials of LODOTRA. In addition to these product candidates, the Company has a pipeline of earlier-stage product candidates to treat pain-related diseases and chronic inflammation.

Brean Capital
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/8/2015 8:25 AM Buy
14.41 18.00
as of 8/27/2015
1 Week down  -7.28 %
1 Month down  -10.50 %
3 Months up  7.99 %
1 YTD up  112.83 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy